Loss of synapses, or communication-conveying connections between one nerve cell and another, does not explain the early cognitive impairment in…
Articles by José Lopes, PhD
A novel strategy using healthy plasma infusions led to promising results in patients with mild to moderate Alzheimer’s disease,…
M3 Biotechnology will test a regenerative therapy for Alzheimer’s in a Phase 1 clinical trial. The Seattle-based company designed NDX-1017…
University of Maryland students have developed a device to diagnose Alzheimer’s before its symptoms are evident. It uses sounds to detect…
The first participant in a Phase 1 clinical trial of HTL0016878 as a treatment for cognitive impairment in Alzheimer’s disease is…
The link between brain inflammation, cell growth and division, and neuronal death could provide a target to treat Alzheimer’s and…
Odor identification tests may help track Alzheimer’s disease (AD) in persons at risk even before the onset of symptoms, a…
New results from its intepirdine (RVT-101) and nelotanserin research programs on Alzheimer’s disease (AD) and Lewy body dementia will be shared…
Researchers have discovered a common link between abnormal proteins that cause damage to brain cells…
A new DNA vaccine protects against accumulation of toxic proteins in Alzheimer’s disease, according to new research. One study, “…